Delivery Order SPE2DB22D3301-SPE2DB25FY2UU

Award Date 4/7/25
Potential Completion Date 4/28/25
Potential Value $5.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,777.72 firm fixed-price delivery order is for BENLYSTA 400 MG VIALS, with a completion date of June 6, 2025. The contract is not set aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a...
This is a $5,038.00 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BENLYSTA 400 MG VIALS. The award has an ultimate completion date of October 15, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive range...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BENLYSTA 120 mg vials, a specialty medication, with a ceiling value of $3,138.40 and a period of performance through January 2, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide BENLYSTA 400 MG VIALS to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $2,519.00 and an ultimate completion date of December 9, 2024. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 120 mg vials of the pharmaceutical product BENLYSTA. The contract has a ceiling value of $2,275.20 and an ultimate completion date of September 3, 2024. It is a firm-fixed-price contract, with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, will be delivering the BENLYSTA vials to support the healthcare needs of federal agencies and...
The U.S. Defense Logistics Agency (DLA) awarded a $7,557 firm-fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office division. The award is for the supply of 400 mg vials of the pharmaceutical product BENLYSTA. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for providing a comprehensive range of medical commodities to military treatment programs and facilities...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BENLYSTA 400 MG VIALS, with a ceiling value of $6,839.28 and a period of performance through June 13, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which provides...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,888.86 firm fixed-price contract is for the delivery of BENLYSTA 400 MG vials. The contract has an ultimate completion date of April 16, 2025 and was awarded on March 26, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which...
This contract is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution subsidiary of Amerisourcebergen Corporation. The $1,259.50 firm fixed price award is for the supply of 400 mg vials of the specialty medication BENLYSTA, with a completion date of March 5, 2024. This delivery order is issued under Amerisourcebergen Drug Corp's existing, single-award indefinite delivery contract (IDC) with DLA, which has a potential value...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of BENLYSTA 120 MG vials. The contract, valued at $2,275.20, is a firm-fixed-price contract with an ultimate completion date of October 16, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these critical pharmaceutical products to support military treatment facilities and other federal healthcare programs. The contract is not set aside and is part...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FY2UU
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BENLYSTA 400 MG VIALS, with a ceiling value of $5,259.24 and a completion date of April 28, 2025. The contract is a Delivery Order under a Firm Fixed Price arrangement, with no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 7/7/25, 1:15 PM